Showing results (161-170 of 317) with videos related to

Sort By:
Pageof 32
Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.
Tumori|August 31, 1986
Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoringC Gambacorti-Passerini, R Marolda, G Tona, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytesG Fossati, A Balsari, D Taramelli, et al.
Cancer Research|February 24, 2001
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsC Castelli, A M Ciupitu, F Rini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2013
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanomaM Maio, R Danielli, V Chiarion-Sileni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1993
Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JYM Altomonte, C Pucillo, G Damante, et al.
Current Drug Targets|April 18, 2003
Endoglin (CD105): a target for anti-angiogenetic cancer therapyE Fonsatti, M Altomonte, P Arslan, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 13, 2001
Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangiesM Maio, M Altomonte, L Calabro, et al.
Pageof 32